Brief: Armata Pharmaceuticals - On March 25, Steve Martin Notified He Intends To Retire As CFO & Senior Vice President Effective As Of June 30, 2022
28/03/2022 22:37
March 28 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS - ON MARCH 25, STEVE MARTIN
NOTIFIED HE
INTENDS TO RETIRE AS CFO & SENIOR VICE PRESIDENT EFFECTIVE AS OF
JUNE 30, 2022
Source text for Eikon: [https://bit.ly/3IGRT4V]
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles